# Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients

Study · id `cardio:ct-nct01115738` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01115738](<https://clinicaltrials.gov/study/NCT01115738>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01115738

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 282 participants.

## Technical summary

Registry record NCT01115738. Randomized; double masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-11 (actual). Results posted on 2012-10-26.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 282 participants (enrolled count; ClinicalTrials.gov record NCT01115738, source copy `cardio:ctgov-nct01115738-2012-11-20`, retrieved 2026-10-31)
- Start date: 2010-05 (registry gives no type) (ClinicalTrials.gov record NCT01115738, source copy `cardio:ctgov-nct01115738-2012-11-20`, retrieved 2026-10-31)
- Primary completion: 2011-11 (actual) (ClinicalTrials.gov record NCT01115738, source copy `cardio:ctgov-nct01115738-2012-11-20`, retrieved 2026-10-31)
- Completion: 2011-11 (actual) (ClinicalTrials.gov record NCT01115738, source copy `cardio:ctgov-nct01115738-2012-11-20`, retrieved 2026-10-31)
- Results first posted: 2012-10-26 (ClinicalTrials.gov record NCT01115738, source copy `cardio:ctgov-nct01115738-2012-11-20`, retrieved 2026-10-31)
- Countries: India (ClinicalTrials.gov record NCT01115738, source copy `cardio:ctgov-nct01115738-2012-11-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01115738-2012-11-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Prasugrel
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Placebo
- Lead sponsor: Eli Lilly and Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Eli Lilly and Company (`cardio:eli-lilly`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial (`cardio:pubmed-24065443`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial (`cardio:pubmed-24718367`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 77cde066e0a6a191327e51bbdabcd6e3e572748ae58587dc57345ff2426751dd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
